Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study

<p>Abstract</p> <p>Background</p> <p>Following <it>Helicobacter pylori</it> eradication in idiopathic parkinsonism (IP), hypokinesia improved but flexor-rigidity increased. Small intestinal bacterial-overgrowth (SIBO) is a candidate driver of the rigidity: h...

Full description

Bibliographic Details
Main Authors: Dobbs R, Charlett André, Dobbs Sylvia M, Weller Clive, A Ibrahim Mohammad A, Iguodala Owens, Smee Cori, Plant J, Lawson Andrew J, Taylor David, Bjarnason Ingvar
Format: Article
Language:English
Published: BMC 2012-10-01
Series:Gut Pathogens
Subjects:
Online Access:http://www.gutpathogens.com/content/4/1/12
id doaj-a56d50b67c8f4eecbb3937be8d53020a
record_format Article
spelling doaj-a56d50b67c8f4eecbb3937be8d53020a2020-11-24T23:22:44ZengBMCGut Pathogens1757-47492012-10-01411210.1186/1757-4749-4-12Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance studyDobbs RCharlett AndréDobbs Sylvia MWeller CliveA Ibrahim Mohammad AIguodala OwensSmee CoriPlant JLawson Andrew JTaylor DavidBjarnason Ingvar<p>Abstract</p> <p>Background</p> <p>Following <it>Helicobacter pylori</it> eradication in idiopathic parkinsonism (IP), hypokinesia improved but flexor-rigidity increased. Small intestinal bacterial-overgrowth (SIBO) is a candidate driver of the rigidity: hydrogen-breath-test-positivity is common in IP and case histories suggest that <it>Helicobacter</it> keeps SIBO at bay.</p> <p>Methods</p> <p>In a surveillance study, we explore relationships of IP-facets to peripheral immune/inflammatory-activation, in light of presence/absence of <it>Helicobacter</it> infection (urea-breath- and/or stool-antigen-test: positivity confirmed by gastric-biopsy) and hydrogen-breath-test status for SIBO (positivity: >20 ppm increment, 2 consecutive 15-min readings, within 2h of 25G lactulose). We question whether any relationships found between facets and blood leukocyte subset counts stand in patients free from anti-parkinsonian drugs, and are robust enough to defy fluctuations in performance consequent on short t½ therapy.</p> <p>Results</p> <p>Of 51 IP-probands, 36 had current or past <it>Helicobacter</it> infection on entry, 25 having undergone successful eradication (median 3.4 years before). Thirty-four were hydrogen-breath-test-positive initially, 42 at sometime (343 tests) during surveillance (2.8 years). Hydrogen-breath-test-positivity was associated inversely with <it>Helicobacter</it>-positivity (OR 0.20 (95% CI 0.04, 0.99), p<0.05).</p> <p>In 38 patients (untreated (17) or on stable long-t½ IP-medication), the higher the natural-killer count, the shorter stride, slower gait and greater flexor-rigidity (by mean 49 (14, 85) mm, 54 (3, 104) mm.s<sup>-1</sup>, 89 (2, 177) Nm.10<sup>-3</sup>, per 100 cells.μl<sup>-1</sup> increment, p=0.007, 0.04 & 0.04 respectively, adjusted for patient characteristics). T-helper count was inversely associated with flexor-rigidity before (p=0.01) and after adjustment for natural-killer count (-36(-63, -10) Nm.10<sup>-3</sup> per 100 cells.μl<sup>-1</sup>, <it>p</it>=0.007). Neutrophil count was inversely associated with tremor (visual analogue scale, p=0.01). Effect-sizes were independent of IP-medication, and not masked by including 13 patients receiving levodopa (except natural-killer count on flexor-rigidity). Cellular associations held after allowing for potentially confounding effect of hydrogen-breath-test or <it>Helicobacter</it> status. Moreover, additional reduction in stride and speed (68 (24, 112) mm & 103 (38, 168) mm.s<sup>-1</sup>, each p=0.002) was seen with <it>Helicobacter</it>-positivity. Hydrogen-breath-test-positivity, itself, was associated with higher natural-killer and T-helper counts, lower neutrophils (p=0.005, 0.02 & 0.008).</p> <p>Conclusion</p> <p>We propose a rigidity-associated subordinate pathway, flagged by a higher natural-killer count, tempered by a higher T-helper, against which <it>Helicobacter</it> protects by keeping SIBO at bay.</p> http://www.gutpathogens.com/content/4/1/12Pathogenesis of Parkinson’s disease<it>Helicobacter</it>Small intestinal bacterial overgrowthBlood leukocytesNatural-killerT-helperNeutrophilsHypokinesiaRigidityTremor
collection DOAJ
language English
format Article
sources DOAJ
author Dobbs R
Charlett André
Dobbs Sylvia M
Weller Clive
A Ibrahim Mohammad A
Iguodala Owens
Smee Cori
Plant J
Lawson Andrew J
Taylor David
Bjarnason Ingvar
spellingShingle Dobbs R
Charlett André
Dobbs Sylvia M
Weller Clive
A Ibrahim Mohammad A
Iguodala Owens
Smee Cori
Plant J
Lawson Andrew J
Taylor David
Bjarnason Ingvar
Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study
Gut Pathogens
Pathogenesis of Parkinson’s disease
<it>Helicobacter</it>
Small intestinal bacterial overgrowth
Blood leukocytes
Natural-killer
T-helper
Neutrophils
Hypokinesia
Rigidity
Tremor
author_facet Dobbs R
Charlett André
Dobbs Sylvia M
Weller Clive
A Ibrahim Mohammad A
Iguodala Owens
Smee Cori
Plant J
Lawson Andrew J
Taylor David
Bjarnason Ingvar
author_sort Dobbs R
title Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study
title_short Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study
title_full Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study
title_fullStr Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study
title_full_unstemmed Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study
title_sort leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. a surveillance study
publisher BMC
series Gut Pathogens
issn 1757-4749
publishDate 2012-10-01
description <p>Abstract</p> <p>Background</p> <p>Following <it>Helicobacter pylori</it> eradication in idiopathic parkinsonism (IP), hypokinesia improved but flexor-rigidity increased. Small intestinal bacterial-overgrowth (SIBO) is a candidate driver of the rigidity: hydrogen-breath-test-positivity is common in IP and case histories suggest that <it>Helicobacter</it> keeps SIBO at bay.</p> <p>Methods</p> <p>In a surveillance study, we explore relationships of IP-facets to peripheral immune/inflammatory-activation, in light of presence/absence of <it>Helicobacter</it> infection (urea-breath- and/or stool-antigen-test: positivity confirmed by gastric-biopsy) and hydrogen-breath-test status for SIBO (positivity: >20 ppm increment, 2 consecutive 15-min readings, within 2h of 25G lactulose). We question whether any relationships found between facets and blood leukocyte subset counts stand in patients free from anti-parkinsonian drugs, and are robust enough to defy fluctuations in performance consequent on short t½ therapy.</p> <p>Results</p> <p>Of 51 IP-probands, 36 had current or past <it>Helicobacter</it> infection on entry, 25 having undergone successful eradication (median 3.4 years before). Thirty-four were hydrogen-breath-test-positive initially, 42 at sometime (343 tests) during surveillance (2.8 years). Hydrogen-breath-test-positivity was associated inversely with <it>Helicobacter</it>-positivity (OR 0.20 (95% CI 0.04, 0.99), p<0.05).</p> <p>In 38 patients (untreated (17) or on stable long-t½ IP-medication), the higher the natural-killer count, the shorter stride, slower gait and greater flexor-rigidity (by mean 49 (14, 85) mm, 54 (3, 104) mm.s<sup>-1</sup>, 89 (2, 177) Nm.10<sup>-3</sup>, per 100 cells.μl<sup>-1</sup> increment, p=0.007, 0.04 & 0.04 respectively, adjusted for patient characteristics). T-helper count was inversely associated with flexor-rigidity before (p=0.01) and after adjustment for natural-killer count (-36(-63, -10) Nm.10<sup>-3</sup> per 100 cells.μl<sup>-1</sup>, <it>p</it>=0.007). Neutrophil count was inversely associated with tremor (visual analogue scale, p=0.01). Effect-sizes were independent of IP-medication, and not masked by including 13 patients receiving levodopa (except natural-killer count on flexor-rigidity). Cellular associations held after allowing for potentially confounding effect of hydrogen-breath-test or <it>Helicobacter</it> status. Moreover, additional reduction in stride and speed (68 (24, 112) mm & 103 (38, 168) mm.s<sup>-1</sup>, each p=0.002) was seen with <it>Helicobacter</it>-positivity. Hydrogen-breath-test-positivity, itself, was associated with higher natural-killer and T-helper counts, lower neutrophils (p=0.005, 0.02 & 0.008).</p> <p>Conclusion</p> <p>We propose a rigidity-associated subordinate pathway, flagged by a higher natural-killer count, tempered by a higher T-helper, against which <it>Helicobacter</it> protects by keeping SIBO at bay.</p>
topic Pathogenesis of Parkinson’s disease
<it>Helicobacter</it>
Small intestinal bacterial overgrowth
Blood leukocytes
Natural-killer
T-helper
Neutrophils
Hypokinesia
Rigidity
Tremor
url http://www.gutpathogens.com/content/4/1/12
work_keys_str_mv AT dobbsr leukocytesubsetcountsinidiopathicparkinsonismprovidecluestoapathogenicpathwayinvolvingsmallintestinalbacterialovergrowthasurveillancestudy
AT charlettandre leukocytesubsetcountsinidiopathicparkinsonismprovidecluestoapathogenicpathwayinvolvingsmallintestinalbacterialovergrowthasurveillancestudy
AT dobbssylviam leukocytesubsetcountsinidiopathicparkinsonismprovidecluestoapathogenicpathwayinvolvingsmallintestinalbacterialovergrowthasurveillancestudy
AT wellerclive leukocytesubsetcountsinidiopathicparkinsonismprovidecluestoapathogenicpathwayinvolvingsmallintestinalbacterialovergrowthasurveillancestudy
AT aibrahimmohammada leukocytesubsetcountsinidiopathicparkinsonismprovidecluestoapathogenicpathwayinvolvingsmallintestinalbacterialovergrowthasurveillancestudy
AT iguodalaowens leukocytesubsetcountsinidiopathicparkinsonismprovidecluestoapathogenicpathwayinvolvingsmallintestinalbacterialovergrowthasurveillancestudy
AT smeecori leukocytesubsetcountsinidiopathicparkinsonismprovidecluestoapathogenicpathwayinvolvingsmallintestinalbacterialovergrowthasurveillancestudy
AT plantj leukocytesubsetcountsinidiopathicparkinsonismprovidecluestoapathogenicpathwayinvolvingsmallintestinalbacterialovergrowthasurveillancestudy
AT lawsonandrewj leukocytesubsetcountsinidiopathicparkinsonismprovidecluestoapathogenicpathwayinvolvingsmallintestinalbacterialovergrowthasurveillancestudy
AT taylordavid leukocytesubsetcountsinidiopathicparkinsonismprovidecluestoapathogenicpathwayinvolvingsmallintestinalbacterialovergrowthasurveillancestudy
AT bjarnasoningvar leukocytesubsetcountsinidiopathicparkinsonismprovidecluestoapathogenicpathwayinvolvingsmallintestinalbacterialovergrowthasurveillancestudy
_version_ 1725566597646516224